Kurtán KittiDr. Kovács TamásDr. Zákány Florina2023-12-132023-12-132023-12https://hdl.handle.net/2437/362307VEKLURY® (REMDESIVIR) FORMULATIONS INHIBIT INITIAL MEMBRANE-COUPLED EVENTS OF SARS-COV-2 INFECTION DUE TO THEIR CYCLODEXTRIN CONTENT